Cited by 307Advanced Causal Inference TechniquesStatistical Methods in EpidemiologyMeta-analysis and systematic reviews

Good Research Practices for Comparative Effectiveness Research: Approaches to Mitigate Bias and Confounding in the Design of Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retrospective Database Analysis Task Force Report—Part II

Open access
Cox, Emily, Martin, Bradley C., Van Staa, Tjeerd, Garbe, Edeltraut, Siebert, Uwe, Johnson, Michael L.·2009·Value in Health

Abstract

Objectives The goal of comparative effectiveness analysis is to examine the relationship between two variables, treatment, or exposure and effectiveness or outcome. Unlike data obtained through randomized controlled trials, researchers face greater challenges with causal inference with observational studies. Recognizing these challenges, a task force was formed to develop a guidance document on methodological approaches to addresses these biases. Methods The task force was commissioned and a Chair was selected by the International Society for Pharmacoeconomics and Outcomes Research Board of Directors in October 2007. This report, the second of three reported in this issue of the Journal, discusses the inherent biases when using secondary data sources for comparative effectiveness analysis and provides methodological recommendations to help mitigate these biases. Results The task force report provides recommendations and tools for researchers to mitigate threats to validity from bias and confounding in measurement of exposure and outcome. Recommendations on design of study included: the need for data analysis plan with causal diagrams; detailed attention to classification bias in definition of exposure and clinical outcome; careful and appropriate use of restriction; extreme care to identify and control for confounding factors, including time-dependent confounding. Conclusions Design of nonrandomized studies of comparative effectiveness face several daunting issues, including…

Integrity signals

Registry

Crossref · 10.1111/j.1524-4733.2009.00601.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
Cox, E., Martin, B. C., Van Staa, T., Garbe, E., Siebert, U., & Johnson, M. L.
Affiliations
  • Express Scripts Holding Company (United States) (US)
  • University of Arkansas for Medical Sciences (US)
  • Leibniz Institute for Prevention Research and Epidemiology - BIPS (DE)
  • Harvard University (US)
  • University of Houston (US)
Venue
Value in Health
Publisher
Elsevier BV
Published
2009-11
Volume
12
Issue
8
Pages
1053-1061
ISSN
1098-3015 (ISSN-L)
OpenAlex
W2121797973
Cited by
307
References
2
Citations by year
2026: 4 · 2025: 9 · 2024: 11 · 2023: 7 · 2022: 25 · 2021: 19 · 2020: 25 · 2019: 26 · 2018: 19 · 2017: 24 · 2016: 23 · 2015: 24 · 2014: 22 · 2013: 22 · 2012: 17
FWCI
13.00
Type
journal article
Language
en
Open access
Locations
  • Value in Health (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
Topics
  • Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Epidemiology
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
Keywords
comparative effectiveness research, observational studies, confounding, bias, secondary data sources, causal graphs, restriction, misclassification bias, time-varying confounding, research design, generalizability, treatment effects
MeSH terms
Data Collection, Data Interpretation, Statistical, Decision Making, Health Policy, Humans, Retrospective Studies, United States, Selection Bias, Confounding Factors, Epidemiologic, Databases, Factual, Outcome Assessment, Health Care, Economics, Pharmaceutical, Observation, Advisory Committees, Internationality, Comparative Effectiveness Research, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review